Cargando…
Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma
Oral Squamous Cell Carcinoma (OSCC) is the most common oral cancer worldwide. Treatments including surgery, radio- and chemo-therapies mostly result in debilitating side effects. Thus, a more accurate evaluation of patients at risk of recurrence after radio/chemo treatment is important for preservin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190092/ https://www.ncbi.nlm.nih.gov/pubmed/27329590 http://dx.doi.org/10.18632/oncotarget.10005 |